GlassScriptPhysician profile
Randi N Kalich
NPI 1538642608
$1,251.15
in general payments reported to CMS, 2019-2025
15 companies · $77.11 in 2025
The $77.11 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.38 · 2022: $350 · 2023: $367 · 2024: $444 · 2025: $77.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $888.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $569.08 | 2023-2025 | Confirm Rx, Octrode, Aveir |
| Mml US, INC. | $124.35 | 2023 | Reactiv8 |
| Amgen INC. | $122.48 | 2022-2024 | Otezla, Enbrel |
| Zimmer Biomet Holdings, INC. | $92.26 | 2022 | |
| Averitas Pharma INC. | $65.96 | 2024 | Qutenza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.80 | 2022 | |
| Tersera Therapeutics LLC | $40.57 | 2022 | |
| Scilex Pharmaceuticals INC. | $34.00 | 2024 | |
| Collegium Pharmaceutical, INC. | $33.83 | 2022-2023 | Belbuca |
| Abbvie INC. | $28.89 | 2022-2023 | |
| Boston Scientific Corporation | $21.66 | 2022 | |
| Nevro Corp. | $20.67 | 2023 | Senza |
| Impel Pharmaceuticals INC. | $18.86 | 2022 | |
| Medtronic, INC. | $14.36 | 2023 | Intellis Adaptivestim |
| Almatica Pharma LLC | $13.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randi Kalich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.